Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma

Neurosurgical Focus
James P CarusoJason P Sheehan

Abstract

The management of metastatic spinal melanoma involves maximizing local control, preventing recurrence, and minimizing treatment-associated toxicity and spinal cord damage. Additionally, therapeutic measures should promote mechanical stability, facilitate rehabilitation, and promote quality of life. These objectives prove difficult to achieve given melanoma's elusive nature, radioresistant and chemoresistant histology, vascular character, and tendency for rapid and early metastasis. Different therapeutic modalities exist for metastatic spinal melanoma treatment, including resection (definitive, debulking, or stabilization procedures), stereotactic radiosurgery, and immunotherapeutic techniques, but no single treatment modality has proven fully effective. The authors present a conceptual overview and critique of these techniques, assessing their effectiveness, separately and combined, in the treatment of metastatic spinal melanoma. They provide an up-to-date guide for multidisciplinary treatment strategies. Protocols that incorporate specific, goal-defined surgery, immunotherapy, and stereotactic radiosurgery would be beneficial in efforts to maximize local control and minimize toxicity.

References

Aug 3, 1994·Journal of the National Cancer Institute·S A RosenbergD E White
Mar 1, 1996·Archives of Physical Medicine and Rehabilitation·A KuW Nagler
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B AtkinsS A Rosenberg
Mar 11, 2000·Melanoma Research·Z L GokaslanJ A Ellerhorst
Feb 27, 2001·Spine·K TomitaT Akamaru
Apr 3, 2001·The Journal of Experimental Medicine·S Y TsengH Tsuchiya
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M BalchJ F Thompson
Feb 19, 2002·International Journal of Radiation Oncology, Biology, Physics·Lisa J HazardR Dirk Noyes
Aug 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·James L RileyPeter S Linsley
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Helga SchneiderChristopher E Rudd
Oct 31, 2002·Seminars in Oncology·Emma CattellMark R Middleton
Feb 6, 2003·Melanoma Research·N P NguyenS Sallah
Dec 14, 2004·Cancer·Yvette M van der LindenUNKNOWN Dutch Bone Metastasis Study Group
Oct 4, 2005·International Journal of Radiation Oncology, Biology, Physics·Sandra DemariaSilvia C Formenti
Oct 18, 2005·Molecular and Cellular Biology·Richard V ParryJames L Riley
Feb 28, 2006·Trends in Immunology·Taku Okazaki, Tasuku Honjo
Mar 15, 2006·Stereotactic and Functional Neurosurgery·Peter C GersztenJohn M Kirkwood
Jun 10, 2006·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·E RichtigJ Smolle
Aug 26, 2006·Science·Helga SchneiderChristopher E Rudd
Mar 10, 2007·Gastroentérologie Clinique Et Biologique·Serge EvrardJean Rosenbaum
Feb 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Yoshiya YamadaZvi Fuks
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·James TsaiGideon Bollag
May 13, 2008·Expert Review of Anticancer Therapy·Robert R McWilliamsPaul D Brown
Jun 3, 2008·International Journal of Radiation Oncology, Biology, Physics·Arjun SahgalEric L Chang
Dec 11, 2008·Metabolic Brain Disease·Aye Mu MyintBrian E Leonard
Apr 3, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Teralee R BurtonSpencer B Gibson
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·M Zahidunnabi DewanSandra Demaria
Feb 12, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S J O'DayJ D Wolchok
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Sep 11, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Milan J SonneveldHarry L A Janssen
Feb 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey WeberUNKNOWN Immunotherapy Task Force of the NCI Investigational Drug Steering Committee
May 11, 2011·Immunotherapy·Courtney Nicholas, Gregory B Lesinski

❮ Previous
Next ❯

Citations

Jan 16, 2016·Journal of Neurosurgery. Spine·Rafael De la Garza-RamosEnrique Caro-Osorio
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ori BarzilaiMark H Bilsky
Jun 22, 2016·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Or Cohen-Inbar, Menashe Zaaroor
Feb 27, 2018·Neurosurgery·Ori BarzilaiMark H Bilsky
May 20, 2020·Dose-response : a Publication of International Hormesis Society·Ming-Xia SunLing Guo
Oct 23, 2020·Journal of Bone Oncology·Giuseppe Di PernaDiego Garbossa
Nov 23, 2019·Journal of Neurosurgery. Spine·Se-Jun ParkKi-Tack Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.